Brief: Altamira Therapeutics Files Prospectus Relates To Resale Of Up To 2.5 Mln Shares By Lincoln Park Capital Fund
June 1 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS LTD FILES PROSPECTUS RELATES TO
RESALE,
FROM TIME TO TIME OF UP TO 2.5 MILLION COMMON SHARES BY LINCOLN
PARK CAPITAL FUND LLC
Source text for Eikon: ID:
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering